<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Differentiation of na√Øve B cells into plasma cells or memory cells occurs in the germinal centers (GCs) of lymph follicles or alternatively via a GC- and T-cell-independent pathway </plain></SENT>
<SENT sid="1" pm="."><plain>It is currently assumed that B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> correlate to <z:mpath ids='MPATH_458'>normal</z:mpath> B-cell differentiation stages, but the precise correlation of several B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> to these two pathways remains controversial </plain></SENT>
<SENT sid="2" pm="."><plain>In the present report, we describe the junctional <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule C (JAM-C), currently identified at the cell-cell border of endothelial cells, as a new B-cell marker with a tightly regulated expression during B-cell differentiation </plain></SENT>
<SENT sid="3" pm="."><plain>Expression of JAM-C in tonsils allows distinction between two CD27+ B-cell subpopulations: JAM-C- GC B cells and JAM-C+ non-germinal B cells </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of JAM-C in different B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> reveals a disease-specific pattern and allows a clear distinction between JAM-C- lymphoproliferative syndromes (<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) and JAM-C+ ones (hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, we propose JAM-C as a new identification tool in B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> diagnosis </plain></SENT>
</text></document>